Symposium on Monoclonal Antibody Therapeutics Held by THSTI

The Translational Health Science and Technology Institute (THSTI) hosted a symposium focused on the discovery and development of monoclonal antibody (mAb) therapeutics, emphasizing the need for collaboration between industry and academia. Experts discussed innovative models for advancing mAb therapies in India, highlighting the importance of indigenous innovation and the Bio-E3 policy aimed at enhancing biotechnological self-reliance. The event featured presentations on novel mAb discovery platforms, development pathways, and cutting-edge advancements in the field, concluding with a panel discussion on fostering collaborations to drive economic growth and social progress.

Source: Original Link

Read more